1. Home
  2. TNON vs TSBX Comparison

TNON vs TSBX Comparison

Compare TNON & TSBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNON
  • TSBX
  • Stock Information
  • Founded
  • TNON 2012
  • TSBX 2015
  • Country
  • TNON United States
  • TSBX United States
  • Employees
  • TNON N/A
  • TSBX N/A
  • Industry
  • TNON Medical Specialities
  • TSBX
  • Sector
  • TNON Health Care
  • TSBX
  • Exchange
  • TNON Nasdaq
  • TSBX Nasdaq
  • Market Cap
  • TNON 6.9M
  • TSBX 7.7M
  • IPO Year
  • TNON 2022
  • TSBX 2023
  • Fundamental
  • Price
  • TNON $1.00
  • TSBX $0.36
  • Analyst Decision
  • TNON Strong Buy
  • TSBX Buy
  • Analyst Count
  • TNON 3
  • TSBX 3
  • Target Price
  • TNON $11.67
  • TSBX $4.75
  • AVG Volume (30 Days)
  • TNON 257.6K
  • TSBX 628.3K
  • Earning Date
  • TNON 05-13-2025
  • TSBX 05-08-2025
  • Dividend Yield
  • TNON N/A
  • TSBX N/A
  • EPS Growth
  • TNON N/A
  • TSBX N/A
  • EPS
  • TNON N/A
  • TSBX N/A
  • Revenue
  • TNON $3,284,000.00
  • TSBX N/A
  • Revenue This Year
  • TNON $46.26
  • TSBX N/A
  • Revenue Next Year
  • TNON $58.02
  • TSBX N/A
  • P/E Ratio
  • TNON N/A
  • TSBX N/A
  • Revenue Growth
  • TNON 2.18
  • TSBX N/A
  • 52 Week Low
  • TNON $0.91
  • TSBX $0.29
  • 52 Week High
  • TNON $15.79
  • TSBX $3.05
  • Technical
  • Relative Strength Index (RSI)
  • TNON 37.47
  • TSBX 56.52
  • Support Level
  • TNON $0.98
  • TSBX $0.32
  • Resistance Level
  • TNON $1.35
  • TSBX $0.38
  • Average True Range (ATR)
  • TNON 0.05
  • TSBX 0.03
  • MACD
  • TNON -0.00
  • TSBX 0.00
  • Stochastic Oscillator
  • TNON 9.52
  • TSBX 78.89

About TNON Tenon Medical Inc.

Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

Share on Social Networks: